Market Tracker

02/27 6:02pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.57
Delayed Data
As of Feb 27
 -0.0184 / -3.13%
Today’s Change
0.53
Today|||52-Week Range
1.46
-21.92%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.59
Today’s open0.59
Day’s range0.57 - 0.60
Volume681,899
Average volume (3 months)624,920
Market cap$49.9M
Dividend yield--
Data as of 4:03pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-6.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.24

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...-0.14-8.34%
CASICASI Pharmaceuticals...+0.06+3.85%
--Protea Biosciences G...-0.08-12.14%
PBMDPrima BioMed Ltd+0.14+16.31%
Data as of 3:56pm ET, 02/27/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts